drugset / Trial / NCT02381132

A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain

NCT02381132

Phase 3 Terminated 99 enrolled Neil Singla Mallinckrodt · collab
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to explore the clinical characteristics oral MNK155 and Norco® 7.5mg/325mg when used for the treatment of moderate to severe post operative pain.

Timeline

Start
2014-11
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator COV155 Unknown Oral
Comparator Hydrocodone Unknown Oral

Indications

No indication recorded.